Mushtaq A Siddiqi
Overview
Explore the profile of Mushtaq A Siddiqi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
505
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lone S, Bhat A, Wani N, Karedath T, Hashem S, Nisar S, et al.
Semin Cell Dev Biol
. 2021 Apr;
124:3-14.
PMID: 33926791
The immune system is a well-known vital regulator of tumor growth, and one of the main hallmarks of cancer is evading the immune system. Immune system deregulation can lead to...
2.
Bhat A, Yousuf P, Wani N, Rizwan A, Chauhan S, Siddiqi M, et al.
Signal Transduct Target Ther
. 2021 Feb;
6(1):93.
PMID: 33637674
No abstract available.
3.
Bhat A, Yousuf P, Wani N, Rizwan A, Chauhan S, Siddiqi M, et al.
Signal Transduct Target Ther
. 2021 Jan;
6(1):12.
PMID: 33436555
Head and neck squamous cell carcinoma (HNSCC) is a very aggressive disease with a poor prognosis for advanced-stage tumors. Recent clinical, genomic, and cellular studies have revealed the highly heterogeneous...
4.
Bhat A, Nisar S, Maacha S, Carneiro-Lobo T, Akhtar S, Siveen K, et al.
Mol Cancer
. 2021 Jan;
20(1):2.
PMID: 33390169
Esophageal cancer (EC) is a disease often marked by aggressive growth and poor prognosis. Lack of targeted therapies, resistance to chemoradiation therapy, and distant metastases among patients with advanced disease...
5.
Arif S, Pandith A, Tabasum R, Ramzan A, Singh S, Siddiqi M, et al.
J Neurosurg Sci
. 2018 Feb;
PMID: 29444555
The article by Sajad ARIF, Arshad PANDITH, Rehana TABASUM, Altaf RAMZAN, Sarabjeet SINGH, Mushtaq SIDDIQI, Abdul BHAT entitled "SIGNIFICANT EFFECT OF ANTI-TYROSINE KINASE INHIBITOR (GEFITINIB) ON OVERALL SURVIVAL OF THE...
6.
Syeed N, Sameer A, Abdullah S, Husain S, Siddiqi M
World J Oncol
. 2017 Nov;
1(6):236-241.
PMID: 29147214
Background: TP53 R72P polymorphism has been proposed as a risk factor for breast cancer and is more likely to differ among different ethnic populations. We carried out the study to...
7.
Naikoo N, Rasool R, Shah S, Ahangar A, Siddiqi M, Shah Z
Cancer Genet
. 2017 Oct;
216-217:67-73.
PMID: 29025597
Elevated VEGF mRNA (-ΔC) was significantly associated with adenocarcinoma histology (vs squamous) and advanced NSCLC clinical stages in a univariable analysis; however, this association did not remain significant in the...
8.
Naikoo N, Afroze D, Rasool R, Shah S, Ahangar A, Bhat I, et al.
Asian Pac J Cancer Prev
. 2017 Jul;
18(7):1799-1804.
PMID: 28749108
Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis involving tumor growth and
metastasis. In this large case-control study, we investigated whether functional polymorphisms (+405C>G, +936C>T)
in the...
9.
Sameer A, Syeed N, Tak S, Bashir S, Nissar S, Siddiqi M
Cardiol Res
. 2017 Mar;
1(1):1-7.
PMID: 28352369
Background: The angiotensin-converting enzyme (ACE) gene in humans has an insertion-deletion (I/D) polymorphic state in intron 16 on chromosome 17q23. This polymorphism has been widely investigated in different diseases. In...
10.
Naykoo N, Dil-Afroze , Rasool R, Shah S, Ahangar A, Bhat I, et al.
Gene
. 2017 Jan;
608:95-102.
PMID: 28122267
VEGF contains several polymorphic sites known to influence its expression. We examined the possible association between+405(-634)C>G,+936C>T,-2578C>A and lung cancer in 199 Kashmiri patients and 401 healthy controls. VEGF+405CG,+936CT+TT and-2578CA genotypes...